Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Terminated 4Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gynecologic 2Breast 1

Conditions

Ovarian Neoplasms 9Fallopian Tube Neoplasms 8Breast Neoplasms 6Neoplasms 5Carcinoma, Ovarian Epithelial 5Recurrence 3Prostatic Neoplasms 3Endometrial Neoplasms 3Small Cell Lung Carcinoma 2Metastatic Castration Resistant Prostate Cancer 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor, Unspecified, Adult 1Solid Tumor 1Prostate Cancer Metastatic 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related 1Lung Neoplasms 1Genital Neoplasms, Male 1Genital Neoplasms, Female 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Advanced Solid Tumors 1Advanced Solid Tumor 1Advanced Gastric Cancer 1Adenocarcinoma, Clear Cell 1Adenocarcinoma of Lung 1

Interventions

Docetaxel 158Prednisone 131Leuprolide 95bicalutamide 86enzalutamide 83Radiotherapy 80Goserelin 80Abiraterone Acetate 76acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 54Magnetic Resonance Spectroscopy 46Zoledronic Acid 44gallium 68 PSMA-11 37Flutamide 34abiraterone 32Estramustine 32radium Ra 223 dichloride 30apalutamide 27Surveys and Questionnaires 26Gonadotropin-Releasing Hormone 26Androgen Antagonists 25cabazitaxel 24Radiosurgery 24Dutasteride 22sipuleucel-T 21Prednisolone 21Triptorelin Pamoate 20Paclitaxel 20luprolide acetate gel depot 19Radiation 19Exercise 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms × rucaparib × Clear all
NCT03338790 2026-01-27

CheckMate 9KD

Bristol-Myers Squibb

Phase 2 Completed
292 enrolled 21 charts
Genitourinary

Prostatic Neoplasms

NCT04676334 2024-05-07

CATCH-R

pharmaand GmbH

Phase 3 Completed
34 enrolled 9 charts
GenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Genital Neoplasms, Male, Ovarian Neoplasms, Prostatic Neoplasms

NCT03840200 2023-10-30

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

Hoffmann-La Roche

Phase 1 Completed
51 enrolled 20 charts
BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡